Capital Rx, Inc.

Amendment
CIK: 0001782959·Other·DELAWARE·Filed: Mar 22, 2024
Total Offering

$312,497,075

Amount Sold

$114,999,999

Investors

1

First Sale

Mar 6, 2024

Offering Details

Type
Equity, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
A. J. Loiacono
Related Person
Ryan Kelly
Related Person
Lenard Marcus
Related Person
Kevin Hill
Related Person
Jared Kesselheim
Related Person
Robert Mittendorff
Related Person
Daniel Delmastro
Related Person
Feby Abraham
Related Person

Company

Capital Rx, Inc.

228 Park Avenue S.

New York, NY, 10003

855-538-8897

SEC Filing

0000950157-24-000490

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free